Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | FBP1 | P09467 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | FURIN | P09958 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21881 | 0.87 | TDP1 (0.67) | TP53TDP1ALDH1A1TSHRPTGS2 | |
| SCHEMBL4952188 | 0.87 | NFE2L2 (0.38) | TP53TDP1ALDH1A1TSHRPOLB | |
| Water SCHEMBL20239051 | 0.84 | TDP1 (0.64) | TP53TDP1ALDH1A1TSHRPTGS2 | |
| Ammonia Solution, Strong SCHEMBL31335086 | 0.84 | TDP1 (0.64) | TP53TDP1ALDH1A1TSHRPTGS2 | |
| SCHEMBL30381592 | 0.84 | TDP1 (0.64) | TP53TDP1ALDH1A1TSHRPTGS2 | |
| Hydrochloric Acid SCHEMBL29128956 | 0.81 | TDP1 (0.61) | TP53TDP1ALDH1A1TSHRPTGS2 | |
| Styrene SCHEMBL9639895 | 0.79 | ALDH1A1 (0.78) | TP53TDP1ALDH1A1TSHRPTGS2 | |
| SCHEMBL29128955 | 0.77 | TP53 (0.56) | TP53TDP1ALDH1A1TSHRPTGS2 | |
| SCHEMBL7220206 | 0.75 | — | — | |
| SCHEMBL6521692 | 0.75 | ALDH1A1 (0.54) | TDP1ALDH1A1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8283413-B2 | ink-jet ink; improved stability and dispersibility; polymerized hydrophobic acid-functionalized monomer includes 2-(benzyloxycarbonylmethyl)acrylic acid | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2012-10-09 | — | — | US | disclosed |
| US-20080182934-A1 | Acid-functionalized hydrophobic monomer emulsions, latexes, and associated latexes | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2008-07-31 | — | — | US | disclosed |
| US-20020082357-A1 | Resin and its use in converting morphine to codeine | CORCORAN ROBERT C (US) | 2002-06-27 | — | — | US | disclosed |
| WO-2002028917-A2 | RESIN AND ITS USE IN CONVERTING MORPHINE TO CODEINE | CORCORAN ROBERT C (US) | 2002-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020082357-A1 | Resin and its use in converting morphine to codeine | OPRM1, OPRK1, OPRL1 | TP53 4587/4885TDP1 2605/4885ALDH1A1 1395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.